Please join us for a webinar that will highlight SRS Acquiom’s recently released 2019 Life Sciences M&A Study, which gives a detailed look at deal terms and earnout achievement rates by year, sector and stage of development. The study draws from SRS Acquiom’s experience as a professional shareholder representative on more than 100 structured life sciences deals involving almost 1,000 milestones potentially worth over $30 billion.
Discussions will include:
Key issues in negotiating these agreements
Best practices for optimizing outcomes after the deal is announced
An analysis of which milestones actually get paid, and when